Implied Disease Claims Provision Is Setback For Industry - Hutt
This article was originally published in The Tan Sheet
Executive Summary
Strict implementation and enforcement of the implied disease claims provision in FDA's structure/function claims final rule could mean "lost ground" for dietary supplement firms, eradicating gains resulting from the agency's "retreat" from the proposed "disease" definition, according to attorney Peter Barton Hutt.